Leosdottir Margret, Reimarsdottir Gudrun, Gottskalksson Gizur, Torfason Bjarni, Vigfusdottir Margret, Arnar David O
Department of Cardiology, Malmö University Hospital (UMAS), S-205 02 Malmö, Sweden.
BMC Cardiovasc Disord. 2006 May 24;6:22. doi: 10.1186/1471-2261-6-22.
Indications for implantable cardioverter defibrillator (ICD) implantation have expanded considerably in recent years, resulting in steadily growing numbers of ICD recipients worldwide. The aim of this study was to review the overall experience with ICDs in Iceland.
This was a retrospective single centre study set at the University Hospital in Iceland. Data on all ICD implantations in Iceland from the first implantation in 1992 till the end of 2002 was reviewed.
Sixty-two patients (71% male) received an ICD during this period. There was an increase in the number of implants by year and the number of new implants in 2001 and 2002 amounted to 56 and 38 per million, respectively. The mean age at implantation was 58 (+/-14) years. Forty patients (65%) had coronary artery disease. The most common indications for ICD implantation were cardiac arrest, 32 (52%) and another 26 (42%) had experienced ventricular tachycardia without cardiac arrest. The most common adverse event was inappropriate shocks. Twenty-eight patients (45%) received therapy from their ICDs, with the majority receiving appropriate therapy. Of the thirteen patients deceased before or during the study period, no case of sudden arrhythmic death was observed.
This study shows that the experience with ICDs in Iceland is in most respects similar to other Western countries.
近年来，植入式心脏复律除颤器（ICD）植入的适应证有了显著扩展，导致全球ICD植入者数量稳步增长。本研究旨在回顾冰岛使用ICD的总体经验。
这是一项在冰岛大学医院开展的回顾性单中心研究。回顾了1992年首次植入至2002年底冰岛所有ICD植入的数据。
在此期间，62例患者（71%为男性）接受了ICD植入。每年植入数量有所增加，2001年和2002年新植入数量分别达每百万人口56例和38例。植入时的平均年龄为58（±14）岁。40例患者（65%）患有冠状动脉疾病。ICD植入最常见的适应证是心脏骤停，有32例（52%），另有26例（42%）经历过无心脏骤停的室性心动过速。最常见的不良事件是不恰当电击。28例患者（45%）接受了ICD治疗，大多数接受的是恰当治疗。在研究期间之前或期间死亡的13例患者中，未观察到心律失常性猝死病例。
本研究表明，冰岛使用ICD的经验在大多数方面与其他西方国家相似。
